Endocrine complications of immunotherapies: a review
Author:
Publisher
Royal College of Physicians
Subject
General Medicine
Reference50 articles.
1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2. Endocrine-related adverse events related to immune checkpoint inhibitors: proposed algorithms for management;Del Rivero;Oncologist,2020
3. Corrections to “Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
4. Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
5. Introduction to expert opinion on endocrine complications of new anticancer therapies;Castinetti;Ann Endocrinol (Paris),2018
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endocrine toxicity of cancer immunotherapy;International Journal of Molecular and Immuno Oncology;2024-08-31
2. Immune Checkpoint Inhibitors‐Induced Endocrinopathies: Assessment, Management and Monitoring in a Comprehensive Cancer Centre;Endocrinology, Diabetes & Metabolism;2024-06-26
3. Immunotherapy-Related Hypothyroidism: Mechanisms and Management;Hypothyroidism - Causes, Screening and Therapeutic Approaches [Working Title];2024-05-28
4. Endocrine Adverse Events in Cancer Immunotherapy: From Mechanisms to Clinical Practice;Advances in Cancer Immunotherapy [Working Title];2024-03-29
5. A Case of Myxedema Coma and Adrenal Insufficiency Post Pembrolizumab;Case Reports in Endocrinology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3